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Summary
We aimed to determine the prognostic value of wall
motion assessment during high-dose dobutamine stress
cardiac magnetic resonance imaging (DCMR) for the
prediction of hard cardiac events in a large patient
cohort and within a long follow-up duration. DCMR
can accurately identify between patients with inducible
ischemia who are at increased risk for future hard car-
diac events and revascularization procedures. Within the
‘primary warranty time’ of 3 years after DCMR excellent
outcomes (annual hard cardiac event rate <1%) are
recorded in patients with normal findings.
Background
We aimed to determine the prognostic value of wall
motion assessment during high-dose dobutamine stress
cardiac magnetic resonance imaging (DCMR) for the
prediction of hard cardiac events in a large patient
cohort and within a long follow-up duration.
Methods
Consecutive patients with suspected or known coronary
artery disease underwent DCMR at two experienced car-
diac-MRI centers (German Heart Institute Berlin and
Heidelberg University Hospital), using a standard proto-
col with a 1.5T Philips MR-scanner. Wall motion was
assessed at rest and during maximum stress, and out-
come data including cardiac death and non-fatal myo-
cardial infarction (defined as hard cardiac events) and
‘late’ revascularization (percutaneous coronary interven-
tion or coronary artery bypass grafting) performed >90
days after the MR-scans were prospectively collected at
least 6 months after DCMR.
Results
Follow-up data were available in 3138 consecutive
patients (mean follow-up 3.3±1.7 years, range 0.5 and
9.7 years). Hard cardiac events occurred in 183 (5.8%)
patients during the follow-up period. Patients with an
inducible wall motion abnormality (WMA) experienced
hard cardiac events and late revascularization at signifi-
cantly higher rates (hazard ratio (HR): 6.9; 95%; confi-
dence interval (CI): 4.9-9.7, and HR=3.8; 95%CI=2.9-5.0,
respectively, p<0.001 for both) (Figure 1) compared to
those with normal findings. Within the first 3 years of
follow-up excellent outcomes were recorded for patients
with normal wall motion during stress in regard to hard
cardiac events and late revascularization procedures
(annual hard cardiac event rate of 0.6% and revasculari-
zation rate of 1.6%). Over the following 3 years of follow
up, annual event rates rose for both hard events and
revascularization to 1.6% and 3.2%, respectively.
Using multivariate regression analysis, inducible WMA
during stress, yielded the strongest independent prog-
nostic value for both, hard cardiac events and late revas-
cularization, clearly surpassing that of clinical and
baseline MR-parameters (HR=7.4, 95%CI=3.3-16.7 for
hard cardiac events and HR=3.1, 95%CI=1.7-5.5 for late
revascularization, p<0.001).
Interestingly, patients without inducible ischemia who
underwent early revascularization yielded similar hard
cardiac event rates, compared to those who were contin-
ued on medical treatment. Conversely, patients with
inducible ischemia and early revascularization yielded
significantly improved prognosis compared to patients
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treatment (Figure 2).
Conclusions
DCMR can accurately identify between patients with
inducible ischemia who are at increased risk for future
hard cardiac events and revascularization procedures.
Within the ‘p r i m a r yw a r r a n t yt i m e ’ of 3 years after
DCMR excellent outcomes (annual hard cardiac event
rate <1%) are recorded in patients with normal findings.
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